Circulating tumor cells as Trojan Horse for understanding, preventing, and treating cancer: a critical appraisal

[1]  G. Pond,et al.  Circulating Tumor DNA Alterations in Advanced Urothelial Carcinoma and Association with Clinical Outcomes: A Pilot Study. , 2020, European urology oncology.

[2]  Luis Enrique Cortés-Hernández,et al.  Circulating tumor cell as the functional aspect of liquid biopsy to understand the metastatic cascade in solid cancer. , 2020, Molecular aspects of medicine.

[3]  Nuno A. Fonseca,et al.  A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns , 2020, Nature Communications.

[4]  R. Germain,et al.  Cancer prognosis with shallow tumor RNA sequencing , 2020, Nature Medicine.

[5]  A. Papavassiliou,et al.  PIWI family proteins as prognostic markers in cancer: a systematic review and meta-analysis , 2019, Cellular and Molecular Life Sciences.

[6]  P. Hwu,et al.  Long-term overall survival and prognostic score predicting survival: the IMPACT study in precision medicine , 2019, Journal of Hematology & Oncology.

[7]  S. Limaye,et al.  Circulating ensembles of tumor‐associated cells: A redoubtable new systemic hallmark of cancer , 2019, International journal of cancer.

[8]  Hongmei Chen,et al.  Capturing and Clinical Applications of Circulating Tumor Cells with Wave Microfluidic Chip , 2019, Applied Biochemistry and Biotechnology.

[9]  P. Timpson,et al.  Fluids and their mechanics in tumour transit: shaping metastasis , 2019, Nature Reviews Cancer.

[10]  Richard Shine,et al.  Increased Adaptive Variation Despite Reduced Overall Genetic Diversity in a Rapidly Adapting Invader , 2019, Front. Genet..

[11]  R. Zamarchi,et al.  Single-Cell Analysis of Circulating Tumor Cells: How Far Have We Come in the -Omics Era? , 2019, Front. Genet..

[12]  Alexander van Oudenaarden,et al.  Unravelling cellular relationships during development and regeneration using genetic lineage tracing , 2019, Nature Reviews Molecular Cell Biology.

[13]  B. Carter,et al.  Characterization of plasma-derived protoporphyrin-IX-positive extracellular vesicles following 5-ALA use in patients with malignant glioma , 2019, EBioMedicine.

[14]  V. Zharov,et al.  New Frontiers in Diagnosis and Therapy of Circulating Tumor Markers in Cerebrospinal Fluid In Vitro and In Vivo , 2019, Cells.

[15]  A. Bardelli,et al.  How liquid biopsies can change clinical practice in oncology. , 2019 .

[16]  D. Mavroudis,et al.  PIK3CA hotspot mutations in circulating tumor cells and paired circulating tumor DNA in breast cancer: a direct comparison study , 2019, Molecular oncology.

[17]  K. Kinzler,et al.  Performance of novel non-invasive urine assay UroSEEK in cohorts of equivocal urine cytology , 2019, Virchows Archiv.

[18]  Scott R. Kennedy,et al.  Cancer-Associated Mutations but No Cancer: Insights into the Early Steps of Carcinogenesis and Implications for Early Cancer Detection. , 2019, Trends in cancer.

[19]  Asher Mullard.  FDA notches up third tissue-agnostic cancer approval , 2019, Nature Reviews Drug Discovery.

[20]  Asher Mullard.  Gene therapy boom continues , 2019, Nature Reviews Drug Discovery.

[21]  K. Kinzler,et al.  Applications of liquid biopsies for cancer , 2019, Science Translational Medicine.

[22]  Yuanxin Chen,et al.  Engineering “self-homing” circulating tumour cells as novel cancer theranostics , 2019, bioRxiv.

[23]  L. Wood,et al.  Liquid Biopsy as Surrogate for Tissue for Molecular Profiling in Pancreatic Cancer: A Meta-Analysis Towards Precision Medicine , 2019, Cancers.

[24]  M. Wong,et al.  Circulating Hybrid Cells Join the Fray of Circulating Cellular Biomarkers , 2019, Cellular and molecular gastroenterology and hepatology.

[25]  K. Pantel,et al.  Liquid biopsy and minimal residual disease — latest advances and implications for cure , 2019, Nature Reviews Clinical Oncology.

[26]  L. Carrascosa,et al.  DNA Methylation-Based Point-of-Care Cancer Detection: Challenges and Possibilities. , 2019, Trends in molecular medicine.

[27]  M. Heikenwalder,et al.  The role of polarisation of circulating tumour cells in cancer metastasis , 2019, Cellular and Molecular Life Sciences.

[28]  L. Wood,et al.  Why is pancreatic cancer so deadly? The pathologist's view , 2019, The Journal of pathology.

[29]  Stuart S. Martin,et al.  Insights on CTC Biology and Clinical Impact Emerging from Advances in Capture Technology , 2019, Cells.

[30]  Lisa M Haley,et al.  Circulating Tumor DNA as a Clinical Test in Resected Pancreatic Cancer , 2019, Clinical Cancer Research.

[31]  H. Nielsen,et al.  Genome-wide cell-free DNA fragmentation in patients with cancer , 2019, Nature.

[32]  J. Thiery,et al.  Circulating Tumor Cell cluster phenotype allows monitoring response to treatment and predicts survival , 2019, Scientific Reports.

[33]  C. Curtis,et al.  Quantitative evidence for early metastatic seeding in colorectal cancer , 2019, Nature Genetics.

[34]  S. Lee,et al.  Technologies for circulating tumor cell separation from whole blood , 2019, Journal of Hematology & Oncology.

[35]  M. Čemažar,et al.  The Biology and Clinical Potential of Circulating Tumor Cells , 2019, Radiology and oncology.

[36]  K. M. McSweeney,et al.  Fugitives on the run: circulating tumor cells (CTCs) in metastatic diseases , 2019, Cancer and Metastasis Reviews.

[37]  G. Pond,et al.  Circulating tumor DNA alterations in patients with metastatic castration‐resistant prostate cancer , 2019, Cancer.

[38]  Xingzhong Zhao,et al.  Sensitive and specific detection of circulating tumor cells promotes precision medicine for cancer , 2019, Journal of Cancer Metastasis and Treatment.

[39]  J. Covington,et al.  Colorectal cancer and adenoma screening using urinary volatile organic compound (VOC) detection: early results from a single-centre bowel screening population (UK BCSP) , 2019, Techniques in Coloproctology.

[40]  B. Abderrahman.  Exhaled breath biopsy: a new cancer detection paradigm. , 2019, Future oncology.

[41]  David Bourque,et al.  Association of Patient Characteristics and Tumor Genomics With Clinical Outcomes Among Patients With Non–Small Cell Lung Cancer Using a Clinicogenomic Database , 2019, JAMA.

[42]  K. Ning,et al.  The diagnostic value of circulating tumor cells and ctDNA for gene mutations in lung cancer , 2019, OncoTargets and therapy.

[43]  S. Volinia,et al.  Heterogeneity in Circulating Tumor Cells: The Relevance of the Stem-Cell Subset , 2019, Cancers.

[44]  Mikhail G. Shapiro,et al.  Ultrasound imaging of gene expression in mammalian cells , 2019, Science.

[45]  Johannes G. Reiter,et al.  Consecutive seeding and transfer of genetic diversity in metastasis , 2019, Proceedings of the National Academy of Sciences.

[46]  Romuere Rôdrigues Veloso e Silva,et al.  Deep learning for cell image segmentation and ranking , 2019, Comput. Medical Imaging Graph..

[47]  Nam-Trung Nguyen,et al.  Novel approaches in cancer management with circulating tumor cell clusters , 2019, Journal of Science: Advanced Materials and Devices.

[48]  A. Papavassiliou,et al.  Helicobacter pylori infection and gastric cancer biology: tempering a double-edged sword , 2019, Cellular and Molecular Life Sciences.

[49]  N. Beerenwinkel,et al.  Neutrophils escort circulating tumour cells to enable cell cycle progression , 2019, Nature.

[50]  I. Matos,et al.  Agnostic-Histology Approval of New Drugs in Oncology: Are We Already There? , 2019, Clinical Cancer Research.

[51]  M. Good,et al.  Challenges and strategies for developing efficacious and long-lasting malaria vaccines , 2019, Science Translational Medicine.

[52]  Yang Luo,et al.  The prognostic and therapeutic implications of circulating tumor cell phenotype detection based on epithelial–mesenchymal transition markers in the first-line chemotherapy of HER2-negative metastatic breast cancer , 2019, Cancer communications.

[53]  Hushan Yang,et al.  Association of clinical outcomes in metastatic breast cancer patients with circulating tumour cell and circulating cell-free DNA. , 2019, European journal of cancer.

[54]  F. Castro-Giner,et al.  Circulating Tumor Cell Clustering Shapes DNA Methylation to Enable Metastasis Seeding , 2019, Cell.

[55]  Xinxia Peng,et al.  Circulating tumor cells exit circulation while maintaining multicellularity, augmenting metastatic potential , 2019, Journal of Cell Science.

[56]  C. Brennan,et al.  Tracking Tumor Evolution in Glioma through Liquid Biopsies of Cerebrospinal Fluid , 2018, Nature.

[57]  R. Caporali,et al.  The Clinical Value of Autoantibodies in Rheumatoid Arthritis , 2018, Front. Med..

[58]  Liyuan Wei,et al.  Epithelial‑mesenchymal transition phenotype of circulating tumor cells is associated with distant metastasis in patients with NSCLC. , 2018, Molecular medicine reports.

[59]  Keval Patel,et al.  Enhanced detection of circulating tumor DNA by fragment size analysis , 2018, Science Translational Medicine.

[60]  J. McPherson,et al.  Sensitive tumour detection and classification using plasma cell-free DNA methylomes , 2018, Nature.

[61]  Yu Xu,et al.  Clinicopathological and prognostic significance of circulating tumor cells in patients with esophageal cancer: a meta-analysis , 2018, OncoTargets and therapy.

[62]  Daxiang Cui,et al.  Advances in isolation and detection of circulating tumor cells based on microfluidics , 2018, Cancer biology & medicine.

[63]  G. Koutsodontis,et al.  Surrogates of immunologic cell death (ICD) and chemoradiotherapy outcomes in head and neck squamous cell carcinoma (HNSCC). , 2018, Oral oncology.

[64]  Juanjuan Xiang,et al.  Disseminated tumour cells in bone marrow are the source of cancer relapse after therapy , 2018, Journal of cellular and molecular medicine.

[65]  S. Sleijfer,et al.  Pan-cancer whole genome analyses of metastatic solid tumors , 2018, bioRxiv.

[66]  T. Rose,et al.  Transcriptional response of rice flag leaves to restricted external phosphorus supply during grain filling in rice cv. IR64 , 2018, PloS one.

[67]  D. Barkan,et al.  EMT and Stemness in Tumor Dormancy and Outgrowth: Are They Intertwined Processes? , 2018, Front. Oncol..

[68]  Seonwoo Kim,et al.  Differential impact of circulating tumor cells on disease recurrence and survivals in patients with head and neck squamous cell carcinomas: An updated meta-analysis , 2018, PloS one.

[69]  Johannes G. Reiter,et al.  Minimal functional driver gene heterogeneity among untreated metastases , 2018, Science.

[70]  C. Dive,et al.  Will liquid biopsies improve outcomes for patients with small-cell lung cancer? , 2018, The Lancet. Oncology.

[71]  Johannes G. Reiter,et al.  Precancerous neoplastic cells can move through the pancreatic ductal system , 2018, Nature.

[72]  K. Pavlakis,et al.  ESR1 methylation in primary tumors and paired circulating tumor DNA of patients with high-grade serous ovarian cancer. , 2018, Gynecologic oncology.

[73]  Bernard Siow,et al.  Non-invasive imaging of CSF-mediated brain clearance pathways via assessment of perivascular fluid movement with diffusion tensor MRI , 2018, eLife.

[74]  S. Luoh,et al.  When Tissue Is No Longer the Issue: Tissue-Agnostic Cancer Therapy Comes of Age , 2018, Annals of Internal Medicine.

[75]  T. Elliott,et al.  The newly-arisen Devil facial tumour disease 2 (DFT2) reveals a mechanism for the emergence of a contagious cancer , 2018, eLife.

[76]  N. Loman,et al.  Longitudinal enumeration and cluster evaluation of circulating tumor cells improve prognostication for patients with newly diagnosed metastatic breast cancer in a prospective observational trial , 2018, Breast Cancer Research.

[77]  S. Sleijfer,et al.  Circulating Tumor Cells in Breast Cancer Patients Treated by Neoadjuvant Chemotherapy: A Meta-analysis , 2018, Journal of the National Cancer Institute.

[78]  T. Schlange,et al.  ctDNA and CTCs in Liquid Biopsy – Current Status and Where We Need to Progress , 2018, Computational and structural biotechnology journal.

[79]  G. Pond,et al.  Characterization of metastatic urothelial carcinoma via comprehensive genomic profiling of circulating tumor DNA , 2018, Cancer.

[80]  Peter W. Laird,et al.  Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer , 2018, Cell.

[81]  Ping-Hei Chen,et al.  Optically-induced-dielectrophoresis (ODEP)-based cell manipulation in a microfluidic system for high-purity isolation of integral circulating tumor cell (CTC) clusters based on their size characteristics , 2018 .

[82]  M. Berger,et al.  The value of cell‐free DNA for molecular pathology , 2018, The Journal of pathology.

[83]  Ludmila V. Danilova,et al.  Evaluation of liquid from the Papanicolaou test and other liquid biopsies for the detection of endometrial and ovarian cancers , 2018, Science Translational Medicine.

[84]  C. Gilles,et al.  Epithelial–mesenchymal plasticity and circulating tumor cells: Travel companions to metastases , 2018, Developmental dynamics : an official publication of the American Association of Anatomists.

[85]  J. Utikal,et al.  Single cell polarity in liquid phase facilitates tumour metastasis , 2018, Nature Communications.

[86]  F. DiMeco,et al.  Constitutive and TNFα-inducible expression of chondroitin sulfate proteoglycan 4 in glioblastoma and neurospheres: Implications for CAR-T cell therapy , 2018, Science Translational Medicine.

[87]  P. Marchetti,et al.  Molecular Detection of EMT Markers in Circulating Tumor Cells from Metastatic Non-Small Cell Lung Cancer Patients: Potential Role in Clinical Practice , 2018, Analytical cellular pathology.

[88]  Gustav Stålhammar,et al.  Evolutionary history of metastatic breast cancer reveals minimal seeding from axillary lymph nodes , 2018, The Journal of clinical investigation.

[89]  Ludmila V. Danilova,et al.  Detection and localization of surgically resectable cancers with a multi-analyte blood test , 2018, Science.

[90]  Steven J. M. Jones,et al.  A Hematogenous Route for Medulloblastoma Leptomeningeal Metastases , 2018, Cell.

[91]  F. Castro-Giner,et al.  Beyond Enumeration: Functional and Computational Analysis of Circulating Tumor Cells to Investigate Cancer Metastasis , 2018, Front. Med..

[92]  R. Schiff,et al.  Perspective on Circulating Tumor Cell Clusters: Why It Takes a Village to Metastasize. , 2018, Cancer research.

[93]  James S. Lawson,et al.  Oncogenic Viruses and Breast Cancer: Mouse Mammary Tumor Virus (MMTV), Bovine Leukemia Virus (BLV), Human Papilloma Virus (HPV), and Epstein–Barr Virus (EBV) , 2018, Front. Oncol..

[94]  E. Antonarakis,et al.  CTC-derived AR-V7 detection as a prognostic and predictive biomarker in advanced prostate cancer , 2018, Expert review of molecular diagnostics.

[95]  Wei Zhang,et al.  High Number of Circulating Tumor Cells Predicts Poor Survival of Cutaneous Melanoma Patients in China , 2018, Medical science monitor : international medical journal of experimental and clinical research.

[96]  Hien Dang,et al.  The significance of intertumor and intratumor heterogeneity in liver cancer , 2018, Experimental & Molecular Medicine.

[97]  F. Saad,et al.  Circulating Tumor Cell Number as a Response Measure of Prolonged Survival for Metastatic Castration-Resistant Prostate Cancer: A Comparison With Prostate-Specific Antigen Across Five Randomized Phase III Clinical Trials. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[98]  B. Xiong,et al.  Prognostic and clinicopathological significance of circulating tumor cells detected by RT-PCR in non-metastatic colorectal cancer: a meta-analysis and systematic review , 2017, BMC Cancer.

[99]  Hao Wu,et al.  The significant prognostic value of circulating tumor cells in colorectal cancer: A systematic review and meta-analysis. , 2017, Current problems in cancer.

[100]  W. Guo,et al.  Circulating Tumor Cells from Different Vascular Sites Exhibit Spatial Heterogeneity in Epithelial and Mesenchymal Composition and Distinct Clinical Significance in Hepatocellular Carcinoma , 2017, Clinical Cancer Research.

[101]  B. Rini,et al.  Next-generation sequencing (NGS) of cell-free circulating tumor DNA and tumor tissue in patients with advanced urothelial cancer: a pilot assessment of concordance , 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

[102]  R. Datar,et al.  Multigene methylation analysis of enriched circulating tumor cells associates with poor progression-free survival in metastatic breast cancer patients , 2017, Oncotarget.

[103]  D. Beer,et al.  Poor Prognosis Indicated by Venous Circulating Tumor Cell Clusters in Early-Stage Lung Cancers. , 2017, Cancer research.

[104]  R. Goldbrunner,et al.  Discordance and Conversion Rates of Progesterone-, Estrogen-, and HER2/neu-Receptor Status in Primary Breast Cancer and Brain Metastasis Mainly Triggered by Hormone Therapy. , 2017, Anticancer research.

[105]  M. Nedergaard,et al.  Understanding the functions and relationships of the glymphatic system and meningeal lymphatics. , 2017, The Journal of clinical investigation.

[106]  Chris Dames,et al.  Correspondence: Reply to ‘The experimental requirements for a photon thermal diode’ , 2017, Nature Communications.

[107]  Sam Angiuoli,et al.  Direct detection of early-stage cancers using circulating tumor DNA , 2017, Science Translational Medicine.

[108]  J. Samra,et al.  Circulating and disseminated tumor cells in pancreatic cancer and their role in patient prognosis: a systematic review and meta-analysis , 2017, Oncotarget.

[109]  Yong Wang,et al.  Single-cell DNA sequencing reveals a late-dissemination model in metastatic colorectal cancer , 2017, Genome research.

[110]  J. Condeelis,et al.  Tumor Cell Invadopodia: Invasive Protrusions that Orchestrate Metastasis. , 2017, Trends in cell biology.

[111]  Chee-Jen Chang,et al.  The Prognostic Value of HER2‐Positive Circulating Tumor Cells in Breast Cancer Patients: A Systematic Review and Meta‐Analysis , 2017, Clinical breast cancer.

[112]  K. Pantel,et al.  Characterization of single circulating tumor cells , 2017, FEBS letters.

[113]  Bifeng Yuan,et al.  Three-Dimensional Scaffold Chip with Thermosensitive Coating for Capture and Reversible Release of Individual and Cluster of Circulating Tumor Cells. , 2017, Analytical chemistry.

[114]  Yanhua Hu,et al.  Transdifferentiated Human Vascular Smooth Muscle Cells are a New Potential Cell Source for Endothelial Regeneration , 2017, Scientific Reports.

[115]  Benjamin J. Raphael,et al.  The evolutionary history of 2,658 cancers , 2017, Nature.

[116]  A. Bode,et al.  Circulating Tumor Cells: Moving Biological Insights into Detection , 2017, Theranostics.

[117]  D. Haber,et al.  Microfluidic Isolation of Circulating Tumor Cell Clusters by Size and Asymmetry , 2017, Scientific Reports.

[118]  Xiaoyan Zhang,et al.  Epithelial-to-mesenchymal transition, circulating tumor cells and cancer metastasis: Mechanisms and clinical applications , 2017, Oncotarget.

[119]  Robert H. Brown,et al.  Mutations in the vesicular trafficking protein annexin A11 are associated with amyotrophic lateral sclerosis , 2017, Science Translational Medicine.

[120]  N. Shen,et al.  Meta-analysis Reveals the Prognostic Value of Circulating Tumour Cells Detected in the Peripheral Blood in Patients with Non-Metastatic Colorectal Cancer , 2017, Scientific Reports.

[121]  A. Wu,et al.  Current detection technologies for circulating tumor cells. , 2017, Chemical Society reviews.

[122]  Anthony T Papenfuss,et al.  Circulating tumour DNA reflects treatment response and clonal evolution in chronic lymphocytic leukaemia , 2017, Nature Communications.

[123]  Ghassan Hamarneh,et al.  Evaluation of Three Algorithms for the Segmentation of Overlapping Cervical Cells , 2017, IEEE Journal of Biomedical and Health Informatics.

[124]  Xunbin Wei,et al.  Proportion of circulating tumor cell clusters increases during cancer metastasis , 2017, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[125]  A. Bhardwaj,et al.  In situ click chemistry generation of cyclooxygenase-2 inhibitors , 2017, Nature Communications.

[126]  G. Pazour,et al.  Ror2 signaling regulates Golgi structure and transport through IFT20 for tumor invasiveness , 2017, Scientific Reports.

[127]  Cyrus M. Ghajar,et al.  Circulating and disseminated tumor cells: harbingers or initiators of metastasis? , 2017, Molecular oncology.

[128]  K. Cheng,et al.  Angiopellosis as an Alternative Mechanism of Cell Extravasation , 2017, Stem cells.

[129]  Gong Cheng,et al.  Prognostic Value of Circulating Tumor Cells in Castration Resistant Prostate Cancer: A Meta-analysis. , 2016, Urology journal.

[130]  J. Bergh,et al.  The European Cancer Patient’s Bill of Rights, update and implementation 2016 , 2016, ESMO Open.

[131]  Shuyi Wang,et al.  Prognostic Role of the Circulating Tumor Cells Detected by Cytological Methods in Gastric Cancer: A Meta-Analysis , 2016, BioMed research international.

[132]  Qi Zhang,et al.  Circulating tumor cell clusters: What we know and what we expect (Review) , 2016, International journal of oncology.

[133]  H. Pan,et al.  Circulating tumor cells predict survival benefit from chemotherapy in patients with lung cancer , 2016, Oncotarget.

[134]  N. Aceto,et al.  Recent advances in the biology of human circulating tumour cells and metastasis , 2016, ESMO Open.

[135]  Dafydd G. Thomas,et al.  Heterogeneous estrogen receptor expression in circulating tumor cells suggests diverse mechanisms of fulvestrant resistance , 2016, Molecular oncology.

[136]  Sridhar Ramaswamy,et al.  HER2 expression identifies dynamic functional states within circulating breast cancer cells , 2016, Nature.

[137]  G. Yousef,et al.  Direct Comparison of Metastasis-Related miRNAs Expression Levels in Circulating Tumor Cells, Corresponding Plasma, and Primary Tumors of Breast Cancer Patients. , 2016, Clinical chemistry.

[138]  C. Lim,et al.  Liquid biopsy and therapeutic response: Circulating tumor cell cultures for evaluation of anticancer treatment , 2016, Science Advances.

[139]  M. Jakubowska,et al.  Mechanism of oxidative conversion of Amplex® Red to resorufin: Pulse radiolysis and enzymatic studies. , 2016, Free radical biology & medicine.

[140]  K. Pantel,et al.  Improved Detection of Circulating Tumor Cells in Metastatic Colorectal Cancer by the Combination of the CellSearch® System and the AdnaTest® , 2016, PloS one.

[141]  Stefanie S Jeffrey,et al.  Circulating tumor cell technologies , 2016, Molecular oncology.

[142]  James E. Verdone,et al.  Polyclonal breast cancer metastases arise from collective dissemination of keratin 14-expressing tumor cell clusters , 2016, Proceedings of the National Academy of Sciences.

[143]  K. White,et al.  Tracing the origin of disseminated tumor cells in breast cancer using single-cell sequencing , 2016, Genome Biology.

[144]  P. Fransson,et al.  Oculomotor Deficits after Chemotherapy in Childhood , 2016, PloS one.

[145]  J. Massagué,et al.  Metastatic colonization by circulating tumour cells , 2016, Nature.

[146]  Matthew W. Snyder,et al.  Cell-free DNA Comprises an In Vivo Nucleosome Footprint that Informs Its Tissues-Of-Origin , 2016, Cell.

[147]  C. Tyler-Smith,et al.  Ancient DNA and the rewriting of human history: be sparing with Occam’s razor , 2016, Genome Biology.

[148]  Yinglong Zhang,et al.  Interleukin-6 suppression reduces tumour self-seeding by circulating tumour cells in a human osteosarcoma nude mouse model , 2015, Oncotarget.

[149]  H. Kuerer,et al.  Circulating Tumor Cells and Recurrence After Primary Systemic Therapy in Stage III Inflammatory Breast Cancer. , 2015, Journal of the National Cancer Institute.

[150]  Gary K. Schwartz,et al.  Tumour exosome integrins determine organotropic metastasis , 2015, Nature.

[151]  W. Schulz,et al.  Characterization of DNA Methylation in Circulating Tumor Cells , 2015, Genes.

[152]  A. Zhu,et al.  Hepatocellular Carcinoma: Can Circulating Tumor Cells and Radiogenomics Deliver Personalized Care? , 2015, American journal of clinical oncology.

[153]  R. Weinberg,et al.  Distinct EMT programs control normal mammary stem cells and tumour-initiating cells , 2015, Nature.

[154]  Bénédicte M A Delattre,et al.  PET/MR in Breast Cancer. , 2015, Seminars in nuclear medicine.

[155]  Eshel Ben-Jacob,et al.  Implications of the Hybrid Epithelial/Mesenchymal Phenotype in Metastasis , 2015, Front. Oncol..

[156]  Sridhar Ramaswamy,et al.  A microfluidic device for label-free, physical capture of circulating tumor cell-clusters , 2015, Nature Methods.

[157]  Tomasz Burzykowski,et al.  Circulating tumor cell biomarker panel as an individual-level surrogate for survival in metastatic castration-resistant prostate cancer. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[158]  P. Gao,et al.  Meta-analysis of the prognostic value of circulating tumor cells detected with the CellSearch System in colorectal cancer , 2015, BMC Cancer.

[159]  L. Ellis,et al.  Epithelial–Mesenchymal Transitioned Circulating Tumor Cells Capture for Detecting Tumor Progression , 2014, Clinical Cancer Research.

[160]  Monika Janda,et al.  Systematic Review of Interventions to Improve the Provision of Information for Adults with Primary Brain Tumors and Their Caregivers , 2014, Front. Oncol..

[161]  K. Pantel,et al.  Bone marrow as a reservoir for disseminated tumor cells: a special source for liquid biopsy in cancer patients. , 2014, BoneKEy reports.

[162]  Dimitrios I. Fotiadis,et al.  Machine learning applications in cancer prognosis and prediction , 2014, Computational and structural biotechnology journal.

[163]  G. Barrière,et al.  Circulating tumor cells and epithelial, mesenchymal and stemness markers: characterization of cell subpopulations. , 2014, Annals of translational medicine.

[164]  W. Isaacs,et al.  AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer. , 2014, The New England journal of medicine.

[165]  Sridhar Ramaswamy,et al.  Circulating Tumor Cell Clusters Are Oligoclonal Precursors of Breast Cancer Metastasis , 2014, Cell.

[166]  M. Koch,et al.  Prognostic relevance of minimal residual disease in colorectal cancer. , 2014, World journal of gastroenterology.

[167]  Anna Haeger,et al.  Cell jamming: collective invasion of mesenchymal tumor cells imposed by tissue confinement. , 2014, Biochimica et biophysica acta.

[168]  J. C. Love,et al.  Functional analysis of single cells identifies a rare subset of circulating tumor cells with malignant traits. , 2014, Integrative biology : quantitative biosciences from nano to macro.

[169]  T. Shanafelt,et al.  How we treat Richter syndrome. , 2014, Blood.

[170]  Xuelei Ma,et al.  Prognostic role of circulating tumor cells and disseminated tumor cells in patients with prostate cancer: a systematic review and meta-analysis , 2014, Tumor Biology.

[171]  T. Fehm,et al.  Monitoring in Metastatic Breast Cancer: Is Imaging Outdated in the Era of Circulating Tumor Cells? , 2014, Breast Care.

[172]  Xiaofeng Chen,et al.  Teicoplanin as an Effective Alternative to Vancomycin for Treatment of MRSA Infection in Chinese Population: A Meta-analysis of Randomized Controlled Trials , 2013, PloS one.

[173]  Cheryl Bettigole.  The thousand-dollar Pap smear. , 2013, The New England journal of medicine.

[174]  J. Shrager,et al.  An Observational Study of Circulating Tumor Cells and 18F-FDG PET Uptake in Patients with Treatment-Naive Non-Small Cell Lung Cancer , 2013, PloS one.

[175]  Mina J. Bissell,et al.  The perivascular niche regulates breast tumor dormancy , 2013, Nature Cell Biology.

[176]  Tim Holland-Letz,et al.  Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay , 2013, Nature Biotechnology.

[177]  G. Hays,et al.  Identification of genetically and oceanographically distinct blooms of jellyfish , 2013, Journal of The Royal Society Interface.

[178]  David Basanta,et al.  SP-0013: A mathematical model of tumor self-seeding reveals secondary metastatic deposits as drivers of primary tumor growth , 2013 .

[179]  Sridhar Ramaswamy,et al.  Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition , 2013, Science.

[180]  M. King,et al.  Phenotypic Switch in Blood: Effects of Pro-Inflammatory Cytokines on Breast Cancer Cell Aggregation and Adhesion , 2013, PloS one.

[181]  Richard O Hynes,et al.  The initial hours of metastasis: the importance of cooperative host-tumor cell interactions during hematogenous dissemination. , 2012, Cancer discovery.

[182]  Tao Wang,et al.  Meta-Analysis of the Prognostic Value of Circulating Tumor Cells in Breast Cancer , 2012, Clinical Cancer Research.

[183]  J. Nieva,et al.  Fluid biopsy for solid tumors: a patient's companion for lifelong characterization of their disease. , 2012, Future oncology.

[184]  M. Tatari,et al.  EMT as the ultimate survival mechanism of cancer cells. , 2012, Seminars in cancer biology.

[185]  David Basanta,et al.  A mathematical model of tumour self-seeding reveals secondary metastatic deposits as drivers of primary tumour growth , 2012, Journal of The Royal Society Interface.

[186]  Peter Kuhn,et al.  Characterization of circulating tumor cell aggregates identified in patients with epithelial tumors , 2012, Physical biology.

[187]  A. Corti,et al.  Chromogranin A regulates tumor self-seeding and dissemination. , 2012, Cancer research.

[188]  Junhong Han,et al.  Human Histone Acetyltransferase 1 Protein Preferentially Acetylates H4 Histone Molecules in H3.1-H4 over H3.3-H4* , 2012, The Journal of Biological Chemistry.

[189]  Meenakshi Upreti,et al.  Tumor-Endothelial Cell Three-dimensional Spheroids: New Aspects to Enhance Radiation and Drug Therapeutics. , 2011, Translational oncology.

[190]  G. Hampton,et al.  Evaluation of Circulating Tumor Cells and Circulating Tumor DNA in Non–Small Cell Lung Cancer: Association with Clinical Endpoints in a Phase II Clinical Trial of Pertuzumab and Erlotinib , 2011, Clinical Cancer Research.

[191]  M. Cristofanilli,et al.  Circulating Tumor Cells and PET , 2011, The Journal of Nuclear Medicine.

[192]  Larry Norton,et al.  Clinical implications of cancer self-seeding , 2011, Nature Reviews Clinical Oncology.

[193]  Sophia Hsin-Jung Li,et al.  Paracrine and Autocrine Signals Induce and Maintain Mesenchymal and Stem Cell States in the Breast , 2011, Cell.

[194]  Mehmet Toner,et al.  Circulating tumor cells: approaches to isolation and characterization , 2011, The Journal of cell biology.

[195]  A. Whittemore,et al.  Assessing interactions between the associations of common genetic susceptibility variants, reproductive history and body mass index with breast cancer risk in the breast cancer association consortium: a combined case-control study , 2010, Breast Cancer Research.

[196]  Dai Fukumura,et al.  Malignant cells facilitate lung metastasis by bringing their own soil , 2010, Proceedings of the National Academy of Sciences.

[197]  A. Goldhirsch,et al.  Changes of HER2 status in circulating tumor cells compared with the primary tumor during treatment for advanced breast cancer. , 2010, Clinical breast cancer.

[198]  Pieter Wesseling,et al.  Receptor conversion in distant breast cancer metastases , 2010, Breast Cancer Research.

[199]  T. Fehm,et al.  HER2 status of circulating tumor cells in patients with metastatic breast cancer: a prospective, multicenter trial , 2010, Breast Cancer Research and Treatment.

[200]  Min-Ying Su,et al.  Characterization of Pure Ductal Carcinoma In Situ on Dynamic Contrast-Enhanced MR Imaging: Do Nonhigh Grade and High Grade Show Different Imaging Features? , 2010, Journal of oncology.

[201]  J. Aguirre-Ghiso.  On the theory of tumor self-seeding: implications for metastasis progression in humans , 2010, Breast Cancer Research.

[202]  G. Kallergi,et al.  Circulating tumor cells with a putative stem cell phenotype in peripheral blood of patients with breast cancer. , 2010, Cancer letters.

[203]  Peter Kuhn,et al.  Cytomorphology of Circulating Colorectal Tumor Cells:A Small Case Series , 2010, Journal of oncology.

[204]  Larry Norton,et al.  Tumor Self-Seeding by Circulating Cancer Cells , 2009, Cell.

[205]  Raghu Kalluri,et al.  The basics of epithelial-mesenchymal transition. , 2009, The Journal of clinical investigation.

[206]  A. Rutman,et al.  Radiogenomics: creating a link between molecular diagnostics and diagnostic imaging. , 2009, European journal of radiology.

[207]  Michael Morse,et al.  Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[208]  Wenjun Guo,et al.  The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells , 2008, Cell.

[209]  Glenn Heller,et al.  Circulating Tumor Cell Number and Prognosis in Progressive Castration-Resistant Prostate Cancer , 2007, Clinical Cancer Research.

[210]  J. Nieva,et al.  Case study of the morphologic variation of circulating tumor cells. , 2007, Human pathology.

[211]  Brigitte Rack,et al.  Detection of Circulating Tumor Cells in Peripheral Blood of Patients with Metastatic Breast Cancer: A Validation Study of the CellSearch System , 2007, Clinical Cancer Research.

[212]  G. Strewler,et al.  Clinical and basic research papers - September 2006 selections , 2006 .

[213]  K. Pienta,et al.  Intravascular metastatic cancer cell homotypic aggregation at the sites of primary attachment to the endothelium. , 2003, Cancer research.

[214]  R. Eils,et al.  From latent disseminated cells to overt metastasis: Genetic analysis of systemic breast cancer progression , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[215]  V. Vasioukhin,et al.  The Origin and Mechanism of Circulating DNA , 2000, Annals of the New York Academy of Sciences.

[216]  T. Schlange,et al.  Multicenter Evaluation of Circulating Cell-Free DNA Extraction and Downstream Analyses for the Development of Standardized (Pre)analytical Work Flows. , 2019, Clinical chemistry.

[217]  K. Pantel,et al.  Molecular Diagnostics: Going from Strength to Strength , 2019 .

[218]  John W. Park,et al.  Isolation and Molecular Characterization of Circulating Tumor Cells , 2017 .

[219]  K. Pantel,et al.  Expression of Epithelial Mesenchymal Transition and Cancer Stem Cell Markers in Circulating Tumor Cells. , 2017, Advances in experimental medicine and biology.

[220]  B. Taylor,et al.  Tumor Evolution, Heterogeneity, and Therapy for Our Patients With Advanced Cancer: How Far Have We Come? , 2017, American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting.

[221]  E. Lianidou,et al.  The Role of CTCs as Tumor Biomarkers. , 2015, Advances in experimental medicine and biology.

[222]  Yuquan Wei,et al.  Meta-analysis of circulating tumor cells as a prognostic marker in lung cancer. , 2012, Asian Pacific journal of cancer prevention : APJCP.

[223]  Jian Tu,et al.  A higher number of circulating tumor cells (CTC) in peripheral blood indicates poor prognosis in prostate cancer patients--a meta-analysis. , 2011, Asian Pacific journal of cancer prevention : APJCP.

[224]  E. Kararizou,et al.  Metabolism and cancer: an up-to-date review of a mutual connection. , 2010, Asian Pacific journal of cancer prevention : APJCP.